Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 3

1(14.3%)

Phase 4

1(14.3%)

7Total

N/A(5)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07501442Not ApplicableNot Yet Recruiting

Clinical Trial Evaluating the Efficacy and Safety of Uracil 0,5% Plasters in Oncology Patients Affected by Hand-foot Syndrome (HFS)

Role: collaborator

NCT07413445Not ApplicableNot Yet Recruiting

Prospective Clinical Evaluation of the Safety and Performance of the Aesthetic Medical Device MEC REGENERATE® (Injectable Recombinant Collagen-based Product)

Role: collaborator

NCT07029516Phase 3Recruiting

Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis

Role: collaborator

NCT06336044Not ApplicableRecruiting

Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'

Role: collaborator

NCT06123689Not ApplicableWithdrawn

Safety and Efficacy of AMT-RegeneraActiva in the Management of Knee Osteoarthritis (OA)

Role: collaborator

NCT06839209Not ApplicableRecruiting

Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea

Role: collaborator

NCT05936762Phase 4Completed

Clinical Efficacy and Safety of NEOIAL HC for Intra-articular Use in the Treatment of Severe Knee Osteoarthritis

Role: lead

All 7 trials loaded